(Mannitol 10 % Solution for intravenous injection)
The trading (patented) name of a preparation - MANNI-TECH
The international name -
SOLUTION of MANNITOL 10%
ATC-CODE - B05CB01
> STRUCTURE AND THE FORM OF RELEASE
1 litre of a solution contains
Mannitol ........... 100g
Other components: water for an injection.
250, 400, 500 ml of solution in plastic containers from PVC.
Manni-Tech renders strong diuretic reaction. Effect caused by the increase of osmotic pressure of plasma and move of fluids from tissues (in particular eyeball, brain) in a vascular channel, decrease of water re-absorption. Diuretic effect is characterized by allocation of water, as well as sodium, chlorine, without any essential influence on potassium deduction.
INDICATIONS FOR ADMINISTRATION
Manni-Tech is used to decrease the intracranial pressure and to reduce the hypostasis of brain, oliguria, acute nephros or nephros-hepatic insufficiency with the preserved filtrational ability of kidneys and during other conditions demanding intensity of diuresis. At acute stagnant glaucoma application of Manni-Tech for dehydration is possible. The preparation is prescribed during intensive therapy of convulsive (spasmodic) status.
Manni-Tech is administered intravenously with calibrated infusion device through slow flow or in drops). For prophylaxis purposes it is administered in a single doze at the rate of 0.5 g/kg of body mass, for medical purposes - 1-1.5 g/kg. The daily doze should not exceed 140-180 g. During operations with artificial blood circulation 20-40 g of preparation is directly entered into the infusion device before the start of perfusion.
Symptoms of water-electrolyte balance disturbances are possible: muscular weakness, spasms, dryness in a mouth, thirst, loss of consciousness; a thrombophlebitis, a skin rash, a tachycardia is possible. During the overdosage of the preparation sypmtoms of dehydration may appear (dyspepsia, hallucination etc.).
Manni-Tech it is contra-indicated during infringements of secretory function of kidneys, intracranial haemorrhage, (o)edema of lungs, acute haemostasia in a small circle of blood circulation, increased sensitivity towards mannitol.
PREGNANCY AND LACTATION
Contraindications are not revealed.
Manni-Tech should be administered cautiously to patients with heavy chronic heart disorders, kidney disorders, hyponatriemia. During the administration of the preparation it is necessary to check arterial pressure, diuresis, electrolyte concentration in the blood serum (potassium, sodium). For the prevention of dehydration, introduction of necessary amounts of fluids to the organism is necessary.
STORAGE CONDITIONS AND SHELF LIFE
To be kept in Órdinary conditions at temperature not higher than +25oC. Expiry date - 2 years.